Navigation Links
Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
Date:10/10/2007

- New Trial in Important Patient Subgroup Will Assess Safety and Anti-Viral

Activity -

TUSTIN, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted therapies for the treatment of cancer and hepatitis C virus infection (HCV), today announced that the first patient has been dosed in a clinical trial designed to evaluate the safety and pharmacokinetics of bavituximab in patients co-infected with HCV and the human immunodeficiency virus (HIV). The multi-center trial is being conducted initially at Saint Michael's Medical Center in Newark, NJ under the guidance of Dr. Stephen Smith, director of the Peter Ho Memorial Clinic, the largest HIV/AIDS treatment facility in the state.

"We are delighted that patient treatment has begun in this important clinical trial that was designed to evaluate an extended bavituximab treatment schedule in an important HCV patient population," said Steven W. King, president and CEO of Peregrine. "We believe that bavituximab has the potential to act on both HCV and HIV infections, and this trial gives us our first opportunity to assess the drug's anti-viral activity in this underserved group of patients."

This open-label, dose escalation study will be conducted in approximately 24 patients chronically infected with HCV and HIV. Patient cohorts will receive ascending dose levels of bavituximab weekly for up to eight weeks. HCV and HIV viral titers and other biomarkers will be evaluated, although they are not formal study endpoints.

In the United States alone, an estimated 300,000 individuals are co-infected with HCV and HIV, representing up to
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Peregrine Pharmaceuticals Highlights Significant Advances in the Companys Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting
4. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
5. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
6. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... N.C. , Nov. 25, 2014  At the ... Antonio this October, KaVo Kerr Group was ... Technology Expo, offering attendees the opportunity to see and ... well-respected key opinion leaders deliver lectures on the latest ... Group products include the new DEXIS CariVu Caries Detection ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
(Date:11/26/2014)... 25, 2014  Unilife Corporation (NASDAQ: UNIS, ASX: UNS), ... systems, today announced that its Chairman and CEO, ... Piper Jaffray 26th Annual Healthcare Conference at the New ... December 2, 2014. The conference presentation ... listen only Webcast. To listen, please go to: ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2
... 2011 SurgiCount Medical, Inc., the wholly-owned operating subsidiary ... today announced that it has signed an agreement, effective ... in one of the largest hospital operators in the ... a minimum number of hospitals, SurgiCount and the operator ...
... 28, 2011 ECRI Institute® ( www.ecri.org ), an ... improving patient care, is pleased to announce Grande Ronde ... the winner of its 6th annual Health Devices ... undertaken by an ECRI Institute member healthcare institution that ...
Cached Medicine Technology:SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System 2SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System 3Grande Ronde Hospital Wins ECRI Institute's 2011 Health Devices Achievement Award 2Grande Ronde Hospital Wins ECRI Institute's 2011 Health Devices Achievement Award 3
(Date:11/26/2014)... 27, 2014 AlignLife, a chiropractic ... the kick-off of its annual Toy Drive. With ... go to donate to those in need throughout ... organizations to distribute the donations to those most ... locations will be accepting donations at the clinics ...
(Date:11/26/2014)... November 27, 2014 Recently, DressVe ... special occasion dresses, has unveiled its 2014 Cyber Monday ... these new dresses, up to 90 percent off. The ... Dec. 3. Free delivery is provided for orders above ... women’s dresses, shoes, handbags and other fashion accessories. The ...
(Date:11/26/2014)... 27, 2014 Boxing Day is traditionally ... would receive gifts, known as a "Christmas box", from ... , With the coming of Boxing Day, some people ... smart before every business opportunity, and it has recently ... a site-wide promotion for its global customers. Then people ...
(Date:11/26/2014)... Norwalk Hospital is pleased to ... by the American Nurses Credentialing Center (ANCC). , ... of work environments where nurses can flourish. The ... Norwalk Hospital and identifies it as one of ... an organizations’ commitment to nurses and their contributions ...
(Date:11/26/2014)... Alex Kramer HealthDay ... People with rheumatoid arthritis may be more likely to achieve ... new research. The study found that those who were ... Being underweight also lowered the odds of remission. "Medication ... population," said Dr. Susan Goodman, the study,s lead author and ...
Breaking Medicine News(10 mins):Health News:DressVe.com: Best 2014 Special Monday Sales Online 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 3Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3
... students and junior medical doctors of the Medical College ... have decided to not to run the outpatient departments ... doctors have however promised not to cause any inconvenience ... a ‘parallel OPD’s’ for the benefit of patents. A ...
... substance inside the body of a lobster commonly known as ... may others as a waste//, unhealthy product. The health agency ... eating too much of lobster tomalley. ,The health ... as a liver and pancreas for lobster, can sometimes contain ...
... anti-reservation medicos strike in India, the government on Sunday night ... on quota in central educational institutes// but the students and ... by calling a bandh in Delhi on May 31. ... talks with Federal Minister Oscar Fernandes who followed it up ...
... issue has been put on the national agenda by India's ... more pressing problems. // ,Sam Pitroda was right ... selecting students for institutions of higher education. But his suggested ... (IITs) is not feasible. Already, the existing IITs are facing ...
... The new interim head of the World Health Organization (WHO), ... since assuming office // , confirmed that Dr Anders Nordstrom. ... the support from the people to continue the fight against ... would continue the work of his predecessor Dr Lee Jong-wook, ...
... AIDS. It is waiting for the FDA to give it ... Nasdaq-listed company already sells the kit to hospitals and public ... product would become an important weapon to fight against HIV. ... was made. Statistics show that more than one million Americans ...
Cached Medicine News:Health News:Agitating Doctors Call For Two Day Shut Down Of OPD’ 2Health News:Quota System: Diverting Attention From The Real Problem 2Health News:Quota System: Diverting Attention From The Real Problem 3Health News:Quota System: Diverting Attention From The Real Problem 4
... Biotechnology, Genomic and Proteomic users should ... over Sample Preparation capability for run-to-run ... ventilated centrifuge accommodates 4x750 ml up ... throughput. High throughput screening, research and ...
... common sight in laboratories everywhere, Model ... dependable centrifuge standards for decades in ... Model K's simple, classic design and ... a standard for centrifuge performance, reliability ...
Inquire...
... Use of the Hybridization Oven/Shaker rigidly ... ensuring the stringency of hybridization and ... and reproducible probing of nucleic acids ... Developed for use with radioactive and ...
Medicine Products: